Yarbrough Capital, LLC Dexcom Inc Transaction History

Yarbrough Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	BUY	$114.22 - $140.1 $318,331 - $390,458	2,787 Added 31.18%	11,725 $1.63 Million
Q4 2022 Jan 12, 2023	SELL	$84.98 - $122.67 $260,038 - $375,370	-3,060 Reduced 25.5%	8,938 $0
Q3 2022 Nov 03, 2022	BUY	$76.35 - $94.18 $358,386 - $442,080	4,694 Added 64.27%	11,998 $966,000
Q2 2022 Jul 08, 2022	BUY	$67.99 - $132.89 $357,423 - $698,602	5,257 Added 256.81%	7,304 $544,000
Q1 2022 Apr 14, 2022	BUY	$94.08 - $130.2 $20,791 - $28,774	221 Added 12.1%	2,047 $1.05 Million
Q4 2021 Feb 01, 2022	BUY	$129.87 - $162.82 $237,142 - $297,309	1,826 New	1,826 $980,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Yarbrough Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Yarbrough Capital, LLC with notifications on news.